These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15954870)

  • 1. Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post-term pregnancy.
    Oboro VO; Tabowei TO
    Acta Obstet Gynecol Scand; 2005 Jul; 84(7):628-31. PubMed ID: 15954870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial.
    Meyer M; Pflum J; Howard D
    Obstet Gynecol; 2005 Mar; 105(3):466-72. PubMed ID: 15738009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal misoprostol for cervical ripening at term: comparison of outpatient vs. inpatient administration.
    Chang DW; Velazquez MD; Colyer M; Klaus P; Mallipeddi SK; Rayburn WF
    J Reprod Med; 2005 Oct; 50(10):735-9. PubMed ID: 16320553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus.
    Incerpi MH; Fassett MJ; Kjos SL; Tran SH; Wing DA
    Am J Obstet Gynecol; 2001 Oct; 185(4):916-9. PubMed ID: 11641678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-induction cervical ripening: transcervical foley catheter versus intravaginal misoprostol.
    Adeniji OA; Oladokun A; Olayemi O; Adeniji OI; Odukogbe AA; Ogunbode O; Aimakhu CO; Omigbodun AO; Ilesanmi AO
    J Obstet Gynaecol; 2005 Feb; 25(2):134-9. PubMed ID: 15814391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of a new vaginal misoprostol product specifically labeled for cervical ripening and labor induction.
    Cecatti JG; Tedesco RP; Pires HM; Calderon IM; Faúndes A
    Acta Obstet Gynecol Scand; 2006; 85(6):706-11. PubMed ID: 16752263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bishop score and the outcome of labor induction with misoprostol.
    Szczesny W; Kjøllesdal M; Karlsson B; Nielsen S
    Acta Obstet Gynecol Scand; 2006; 85(5):579-82. PubMed ID: 16752237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preinduction cervical ripening. A randomized trial of intravaginal misoprostol alone vs. a combination of transcervical Foley balloon and intravaginal misoprostol.
    Rust OA; Greybush M; Atlas RO; Jones KJ; Balducci J
    J Reprod Med; 2001 Oct; 46(10):899-904. PubMed ID: 11725734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial.
    McKenna DS; Ester JB; Proffitt M; Waddell KR
    Obstet Gynecol; 2004 Sep; 104(3):579-84. PubMed ID: 15339772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial comparing vaginal misoprostol versus cervical Foley plus oral misoprostol for cervical ripening and labor induction.
    Hill JB; Thigpen BD; Bofill JA; Magann E; Moore LE; Martin JN
    Am J Perinatol; 2009 Jan; 26(1):33-8. PubMed ID: 18850516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between single dose of 50 microg oral misoprostol and 25 microg vaginal misoprostol for labor induction.
    Paisarntantiwong R; Getgan M
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S56-62. PubMed ID: 17722318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the effect of intravaginal misoprostol at 50 and 100 micrograms in cervical ripening and labor induction].
    Reyna-Villasmil E; Guerra-Velásquez M; Torres-Montilla M; Reyna-Villasmil N; Mejia-Montilla J; Labarca-Vincero N
    Invest Clin; 2005 Jun; 46(2):179-86. PubMed ID: 16001749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial.
    Denguezli W; Trimech A; Haddad A; Hajjaji A; Saidani Z; Faleh R; Sakouhi M
    Arch Gynecol Obstet; 2007 Aug; 276(2):119-24. PubMed ID: 17219155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misoprostol dose selection in a controlled-release vaginal insert for induction of labor in nulliparous women.
    Castañeda CS; Izquierdo Puente JC; Leon Ochoa RA; Plasse TF; Powers BL; Rayburn WF
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1071-5. PubMed ID: 16157114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol.
    Colón I; Clawson K; Hunter K; Druzin ML; Taslimi MM
    Am J Obstet Gynecol; 2005 Mar; 192(3):747-52. PubMed ID: 15746667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral and vaginal misoprostol for induction of labor at term: a randomized controlled trial.
    Paungmora N; Herabutya Y; O-Prasertsawat P; Punyavachira P
    J Obstet Gynaecol Res; 2004 Oct; 30(5):358-62. PubMed ID: 15327448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of labor in prolonged pregnancy with unfavorable cervix: comparison of sequential intracervical Foley catheter-intravaginal misoprostol and intravaginal misoprostol alone.
    Ande AB; Ezeanochie CM; Olagbuji NB
    Arch Gynecol Obstet; 2012 Apr; 285(4):967-71. PubMed ID: 22012248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term.
    Zeteroğlu S; Engin-Ustün Y; Ustün Y; Güvercinçi M; Sahin G; Kamaci M
    J Matern Fetal Neonatal Med; 2006 May; 19(5):283-7. PubMed ID: 16753768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-induction cervical ripening with 25 microg and 50 microg vaginal misoprostol in 181 nulliparous parturients.
    Szczesny W; Sandvik L
    J Matern Fetal Neonatal Med; 2009 Mar; 22(3):265-8. PubMed ID: 19330712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.